GEN1047 for Solid Tumors - First in Human (FIH) Trial

Stopped The Sponsor has made a strategic decision to stop the development of GEN1047.

Conditions

• Breast Cancer, Breast Neoplasms
• Endometrial Cancer, Endometrial Neoplasm
• Ovarian Cancer, Ovarian Neoplasms
• Squamous Non Small Cell Lung Cancer (NSCLC-SCC)

Interventions

• BIOLOGICAL: GEN1047 is a bispecific antibody that induces T-cell mediated cytotoxicity of B7H4-positive tumor cells.

Sponsor

Genmab